Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.
Milestones
- 2013 → Founded
- 2017 → Partnered, Series B
- 2021 → IPO; NASDAQ: RXRX
Partner
Leadership
Chris Gibson
Founder & CEO